Make eating a slow, mindful activity
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Injection of exendin-4 into rodents after endotoxin and mTP toxin-induced damage to the substantia nigra striatum could prevent the toxin-induced activation of microglia and inhibit the production of pro-inflammatory cytokines (70)
It typically begins within the first one to three days after an injection, peaks during the first week, and gradually diminishes over the next two to four weeks as your body adjusts to the medication
Note what you ate, how much, and how you felt 1-2 hours later
Moving forward, a concerted effort to include more representative populations in research is essential to fully understand how GLP-1-based treatments influence taste perception across all demographics